Hospital News, Research & Data Analysis

Suboxone (Buprenorphine/Naloxone) is associated with Lower Hospital Readmission Rates for Psychoactive Substance Use Patients at Adcare Hospital Of Worcester based on Real World Evidence Study of Medicare Claims Data

In Adcare Hospital

By: Sara Riascos Apr. 12, 2022

Psychoactive Substance Use is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Suboxone (Buprenorphine/Naloxone) is a combination of buprenorphine and naloxone, used to treat opioid addiction. Studies have shown that Suboxone (Buprenorphine /Naloxone) is effective in reducing opioid use short term relative to placebo.

Suboxone (Buprenorphine/Naloxone) is associated with Lower Hospital Readmission Rates for Narcotic Dependence Patients at Adcare Hospital Of Worcester based on Real World Evidence Study of Medicare Claims Data

In Adcare Hospital

By: Sara Riascos Apr. 04, 2022

Narcotic Dependence is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Suboxone (Buprenorphine/Naloxone) is a combination of buprenorphine and naloxone, used to treat opioid addiction. Studies have shown that Suboxone (Buprenorphine /Naloxone) is effective in reducing opioid use short term relative to placebo.